Soo Ok Lee Selected Research

Lymphoma (Lymphomas)

5/2007

Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Soo Ok Lee Research Topics

Disease

38	Prostatic Neoplasms (Prostate Cancer) 11/2020 - 07/2002
29	Neoplasms (Cancer) 01/2019 - 07/2002
12	Lung Neoplasms (Lung Cancer) 01/2022 - 04/2005
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 01/2014
7	Neoplasm Metastasis (Metastasis) 11/2020 - 03/2006
3	Asthma (Bronchial Asthma) 02/2009 - 01/2006
2	Hypoxia (Hypoxemia) 06/2016 - 09/2015
2	Abdominal Aortic Aneurysm 01/2016 - 10/2015
2	Atherosclerosis 01/2016 - 06/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016 - 01/2013
2	Carcinogenesis 06/2014 - 11/2012
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2014 - 04/2013
2	Liver Neoplasms (Liver Cancer) 01/2014 - 04/2013
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2008 - 01/2007
1	Infections 02/2016
1	Heart Failure 01/2016
1	Cardiomegaly (Heart Hypertrophy) 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Stroke (Strokes) 01/2016
1	Hypertrophy 01/2016
1	Hypertension (High Blood Pressure) 01/2016
1	Hemophilia A (Haemophilia) 01/2016
1	Obesity 01/2016
1	Kidney Calculi (Kidney Stone) 08/2014
1	Nephrolithiasis 08/2014
1	Inflammation (Inflammations) 06/2014
1	Necrosis 02/2014
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2014
1	X-Linked Bulbo-Spinal Atrophy 01/2014
1	Insulin Resistance 01/2013
1	Androgen-Insensitivity Syndrome (Testicular Feminization) 01/2013
1	Lymphoma (Lymphomas) 05/2007
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2007
1	Ovarian Neoplasms (Ovarian Cancer) 05/2007

Drug/Important Bio-Agent (IBA)

27	Androgen Receptors (Androgen Receptor)IBA 11/2020 - 07/2002
25	AndrogensIBA 11/2020 - 07/2002
13	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2003
9	Prostate-Specific Antigen (Semenogelase)IBA 07/2013 - 07/2002
8	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 09/2015
7	LigandsIBA 07/2018 - 04/2005
4	Interleukin-4 (Interleukin 4)IBA 02/2009 - 09/2003
4	SeleniumIBA 07/2006 - 01/2004
3	Death Domain ReceptorsIBA 10/2020 - 01/2018
3	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2020 - 01/2019
3	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 02/2015 - 06/2013
3	Small Interfering RNA (siRNA)IBA 06/2014 - 09/2004
3	NF-kappa B (NF-kB)IBA 01/2008 - 07/2005
3	Hormones (Hormone)IBA 08/2005 - 09/2003
2	LipidsIBA 01/2021 - 01/2016
2	bicalutamide (Casodex)FDA LinkGeneric 11/2020 - 07/2013
2	enzalutamideIBA 11/2020 - 07/2013
2	Mifepristone (RU 486)FDA Link 01/2019 - 01/2019
2	Conditioned Culture MediaIBA 07/2018 - 01/2018
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2017 - 10/2017
2	CytokinesIBA 09/2015 - 09/2004
2	CarcinogensIBA 06/2014 - 04/2005
2	Estrogens (Estrogen)FDA Link 01/2014 - 04/2005
2	Immunoglobulin E (IgE)IBA 02/2009 - 10/2006
1	CateninsIBA 01/2019
1	Myristic Acid (Tetradecanoic Acid)IBA 07/2018
1	phorbolIBA 07/2018
1	Janus Kinase InhibitorsIBA 01/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2016
1	EnzymesIBA 12/2016
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 12/2016
1	CeruleninIBA 08/2016
1	Insulin (Novolin)FDA Link 01/2016
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2016
1	LeptinIBA 01/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	LuciferasesIBA 02/2015
1	Biomarkers (Surrogate Marker)IBA 02/2015
1	OxalatesIBA 08/2014
1	LectinsIBA 06/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2014
1	Oxidized LDL ReceptorsIBA 06/2014
1	LDL Receptors (LDL Receptor)IBA 06/2014
1	IntegrinsIBA 06/2014
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2014
1	Therapeutic UsesIBA 01/2014
1	Phosphotransferases (Kinase)IBA 01/2014
1	cryptotanshinoneIBA 07/2013
1	InterleukinsIBA 06/2013
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 06/2013
1	Thioacetamide (Thioacetamid)IBA 04/2013
1	TocotrienolsIBA 02/2013
1	Glucose (Dextrose)FDA LinkGeneric 01/2013
1	Decitabine FDA Link 11/2012
1	Phenobarbital (Luminal)FDA Link 05/2012
1	Interferon Regulatory FactorsIBA 11/2008
1	Charcoal (Charbon)IBA 09/2007
1	Growth InhibitorsIBA 05/2007

Therapy/Procedure

15	Therapeutics 11/2020 - 07/2002
11	Castration 01/2019 - 02/2009
4	Radiotherapy 06/2019 - 11/2015
2	Transplantation 01/2014 - 04/2013
1	Immunotherapy 03/2018
1	Drug Therapy (Chemotherapy) 09/2015
1	Cell Transplantation 09/2014
1	Liver Transplantation 04/2013